Gwacheon-si, South Korea

Junghyeon Hong

USPTO Granted Patents = 1 

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Junghyeon Hong

Introduction

Junghyeon Hong is a notable inventor based in Gwacheon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies for cancer treatment. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Junghyeon Hong holds a patent for an "Anti-HER2/anti-4-1BB bispecific antibody and use thereof." This innovative patent provides a pharmaceutical composition and a method for treating and/or preventing cancer using the bispecific antibody. His invention represents a promising approach to cancer therapy, targeting specific pathways to enhance treatment efficacy.

Career Highlights

Throughout his career, Junghyeon Hong has worked with prominent companies in the biotechnology sector. He has been associated with Abl Bio Inc. and Yuhan Corporation, where he has contributed to various research and development projects. His experience in these organizations has allowed him to refine his skills and expand his knowledge in the field.

Collaborations

Junghyeon Hong has collaborated with several talented individuals in his field. Notable coworkers include Eun-Jung Lee and Hyejin Chung, who have worked alongside him on various projects. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Junghyeon Hong's contributions to the field of biotechnology, particularly through his patent for bispecific antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…